Gurrola Sandra M
SEC insider (Form 3/4/5 filer). CIK 0001618457. Sr. VP of Finance at Eterna Therapeutics Inc. (ERNA). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 21, 2025. Located in CAMBRIDGE, MA.
Companies Gurrola Sandra M has filed insider reports for
- Eterna Therapeutics Inc. (ERNA): Officer, Sr. VP of Finance
Gurrola Sandra M
CIK: 0001618457
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (50.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ERNA
Eterna Therapeutics Inc.
Officer